Morgan Stanley Lowers Polaris Price Target to 69 Amid Interest Rate and Tariff Concerns Marvell Dell Earnings and Feds Inflation Gauge Set the Tone for the Trading Week JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India TFCI What It Means Pentagon Letter Reveals Location Data Leak Threatens US Military Personnel Why Chasing High Returns May Undermine LongTerm Investment Success Microsoft and Anthropic in Talks for Custom AI Chip Deal After 5 Billion Investment BRC Group Holdings Inc 550 Senior Notes Due 2026 RILYK Q1 2024 Earnings Net Loss Widens Bond Prices Edge Higher SNTI Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline in PreRevenue Phase NovaBridge Biosciences NBP Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Rises 508 ALAB Q1 2026 Earnings EPS Beats Estimates by Over 11 as Stock Rises EQX Q1 2026 Earnings Marginal EPS Miss as Stock Declines Evolv Technologies Q1 2026 Earnings Narrowing Loss Beats Expectations Stock Rises ClevelandCliffs Inc CLF Rebounds 25 as Steel Stock Tests Key Resistance Vishay Precision Group VPG Shows Strength Gains 374 as Shares Approach Resistance ClearBridge Energy Midstream EMO Edges Lower Holds Near 50 as Sector Volatility Persists NexGel Inc NXGL Edges Higher as Stock Tests Key Resistance Level Apex Treasury Corporation APXT Holds Steady Near Resistance as Trading Volume Remains Moderate Micron Shares Surge Toward Best Month Since 1987 Analysts Still See Value Arteris Inc Q1 2026 Earnings Narrower Loss Beats Estimates as Cost Discipline Improves NVNIW Warrants Surge 1282 as PennyStock Speculation Drives Trading Activity Aris Mining ARIS Under Pressure Critical Support Test After 436 Decline Gulfport Energy GPOR Edges Higher as Stock Challenges Key Resistance Zone AdaptHealth Corp AHCO Slips 177 as Stock Tests Key Support Zone Gabelli MultiMedia Trust GGT Holds Steady Near Support as Market Consolidates HNNAZ Holds Steady at 2500 Par as Hennessy Advisors Notes Reflect Stable Credit Profile TrustCo Bank TRST Edges Lower Amid Consolidation Near Key Support Levels Barinthus Biotherapeutics BRNS Pulls Back to Support as Sector Headwinds Persist